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ABSTRACT
Martix metalloproteinases (MMPs), one of the subgroups of the metzincins, are a large family of zinc-de-
pendent endoproteases with multiple roles in extracellular matrix remodelling and modulation of signal-
ling pathways. They are able to cleave all protein components of the extracellular matrix, as well as to acti-
vate or inactivate various signaling molecules, such as receptors, growth factors and adhesion molecules. 
MMPs are associated with many physiological functions such as embryonic development, angiogenesis and 
wound healing. Therefore, these proteinases are considered to be crucial mediators in many biological pro-
cesses. Elevated MMP levels have also been implicated in an increasing number of injuries and disorders, 
such as inflammation, cancer and auto-immune diseases. Recent investigations highlight the beneficial and 
detrimental effects of MMPs in the nervous system in normal and pathological conditions. This review fo-
cuses on the role of MMPs as modulators of fundamental functions in the developing and adult nervous sys-
tem and their potential to improve repair or regeneration after injury.
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1. INTRODUCTION
The family of matrix metalloproteinases 
(MMPs), also called matrixins, has classically been 
described in the context of extracellular matrix 
(ECM) remodelling, which occurs throughout life in 
diverse processes ranging from tissue morphogene-
sis to wound healing. It has been more than 50 years 
since Gross and Lapiere (1) discovered collagenolyt-
ic activity during tadpole tail metamorphosis, which 
was later on revealed as MMP-1, the founding mem-
ber of the family of the matrixins. MMPs have been 
found in vertebrates, invertebrates, and plants. Till 
now 28 members have been discovered out of which 
23 are found in human. They are distinguished from 
other endopeptidases by their dependence on met-
al ions as cofactors, their ability to ECM, and their 
specific evolutionary DNA sequence (2). The vari-
ous MMPs exist as secreted or membrane-bound en-
zymes that require conversion from zymogen to ac-
tive forms through proteolytic processing. The mem-
bers of the MMP family are proteases (3) that collec-
tively can degrade all constituents of the ECM. As a 
result of their potent proteolytic activity, abnormal 
MMP functions can also lead to pathological con-
ditions. MMPs are involved in various normal and 
pathological processes such as morphogenesis, cell 
proliferation, migration, differentiation, tissue re-
pair, angiogenesis, inflammation, tumor invasion, 
and apoptosis by degrading all kinds of extracellu-
lar matrix proteins, cleavage of cell surface receptors, 
and processing a large number of bioactive molecules 
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(4-7). MMPs may affect cell migration by changing 
the cells from an adhesive to nonadhesive phenotype 
and by degrading the ECM (8,9). MMPs may alter 
ECM microenvironment leading to cell proliferation, 
apoptosis, or morphogenesis (10). They may modu-
late the activity of biologically active molecules such 
as growth factors or growth factor receptors by cleav-
ing them or releasing them from the ECM and may 
alter the protease activity by cleaving the enzymes or 
their inhibitors (11,12).
MMPs are involved in a delicate balance be-
tween proteolytic and anti-proteolytic activity to 
confine them in time and space. When this bal-
ance is disturbed, various disease phenotypes are ob-
served ranging from tissue destruction in chronic in-
flammatory conditions, such as rheumatoid arthritis 
and chronic obstructive pulmonary disease, to can-
cer metastasis and neurological disorders (13). Many 
different stimuli, such as growth factors, cytokines 
and reactive oxygen species, can trigger MMP ex-
pression in physiological as well as pathological con-
ditions (14,15). This review describes the structure of 
MMPs and their physiological roles in the develop-
ing and adult nervous system.
2. STRUCTURAL FEATURES OF 
MMPS
2.1. General organization
MMPs are largely excreted proteins with sev-
eral conserved domains (Fig. 1). Structurally, MMPs 
are divided into three domains: an amino-terminal 
propeptide region, an amino-terminal catalytic do-
main (which contains the zinc-binding motif) and 
a carboxy-terminal domain, which has a high level 
of similarity to members of the hemopexin family 
and is involved in ECM substrate binding for many 
MMPs. All MMPs contain the catalytic domain, 
which is shielded off in the inactive form of the en-
zyme by the prodomain (13). The zinc binding motif 
HEXXHXXGXXH in the catalytic domain, and the 
‘‘cysteine switch’’ motif PRCGXPD in the propep-
tide are common structural signatures, where three 
histidines in the zinc binding motif coordinate and 
the cysteine in the propetide coordinate with the 
catalytic zinc ion. This Cys-Zn2+ coordination keeps 
proMMPs inactive by preventing a water molecule 
essential for catalysis from binding to the zinc atom 
(15). The carboxy-terminal hemopexin-like domain 
is a four-bladed β-propeller structure that is present 
in all MMPs except MMP-7 and MMP-26 (matrily-
sin and matrilysin-2). A hinge region, which is short 
in collagenases and long in other MMPs, connects 
the carboxy- and amino-terminal domains. A short 
signal sequence (“pre-domain”) lies at the ami-
no-terminal end of the protein, before the propep-
tide region, and is clipped off as newly synthesized 
MMPs travel to the cell surface.
MMPs are divided into eight subgroups on the 
basis of their domain organization (Table 1). They 
contain signal peptide in the predomain, prodomain 
and catalytic domain which are also shared by oth-
ers besides hemopexin, transmembrane and cyto-
plasmic domain (16). Gelatinases (MMP-2/-9) have a 
unique fibronectin type II-like domain inserted into 
the catalytic site, whereas MT-MMPs have a trans-
membrane domain at the carboxy terminus. Matri-
lysin (MMP-7) lacks the hinge and the carboxyl ter-
minus. Uunlike other MMP groups, the membrane-
type (MT)-MMPs are membrane proteins. MT4-
MMP (MMP-17) and MT6-MMP (MMP-25) are gly-
cosyl-phosphatidylinositol (GPI)-anchored MMPs, 
whereas the other MT-MMPs are transmembrane 
proteins (17). 
2.2. Specific domain features by groups 
Based on domain organization and substrate 
preference, MMP family members are grouped into 
Fig. 1. Basic domain organization of MMPs.
The generic structure shown here describes most MMP 
family members. This includes the following main do-
mains: signal peptide, prodomain (propeptide region) 
with a cysteine residue (SH), catalytic domain with Zn2+ 
active site, hinge region and carboxy-terminal hemo-
pexin-like domain which contains four repeat units. The 
first and fourth are connected by a disulphide bridge (S-
S). The “SH” at the propeptide region denotes the cyste-
ine residue that ligates the zinc in the catalytic domain 
to keep the enzyme inactive. See Table 1 for domain ar-
rangement of each MMP.
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collagenases, gelatinases, stromelysins, matrilysins, 
membrane-type MMPs and “other MMPs” (2,18). 
However, there is much overlap in substrate specific-
ity between subgroups.
 ❖ Collagenases (MMP-1, MMP-8, MMP-13 and 
MMP-18 in Xenopus) cleave interstitial colla-
gens I, II and III into characteristic 3/4 and 1/4 
fragments but they can digest other ECM mol-
ecules and soluble proteins (19). Two other ma-
trixins, i.e., MMP-2 and MMP-14 (MT1-MMP), 
have collagenolytic activity, but they are classi-
fied into other subgroups because of their do-
main compositions.
 ❖ Gelatinases (MMP-2 and MMP-9) readily di-
gest gelatin (denatured collagen) with the help of 
their three fibronectin type II repeats that binds 
to gelatin/collagen. They also digest a number 
of ECM molecules including type IV, V and XI 
collagens, laminin, aggrecan core protein, etc. 
MMP-2, but not MMP-9, digests collagens I, II 
and III in a similar manner to the collagenases. 
The collagenolytic activity of MMP-2 is much 
weaker than MMP-1 in solution, but because 
proMMP-2 is recruited to the cell surface and 
activated by the membrane-bound MT-MMPs, 
it may express reasonable collagenolytic activi-
ty on or near the cell surface.
 ❖ Stromelysins (MMP-3, MMP-10 and MMP-
11) have a domain arrangement similar to that 
of collagenases, but they do not cleave intersti-
tial collagens. MMP-3 and MMP-10 are sim-
ilar in structure and substrate specificity, but 
MMP-11 (stromelysin 3) is distantly relat-
ed. The MMP-11 gene is located on chromo-
some 22, whereas MMP-3 and MMP-10 are on 
chromosome 11, along with MMP-1, -7, -8, -12, 
-20, -26 and -27. MMP-3 and MMP-10 digest 
a number of ECM molecules and participate 
MMP subgroup Structure Members
1) Basic/Common hemopexin
    domain-containing
2) Minimal-domain
3) Gelatin-binding
4) Furin-activated
5) Vitronectin-like motif
6) Membrane Type I
7) Membrane Type I with GPI
8) Membrane Type II
MMP-1, -3, -8, -10, -12, 
-13, -18, -19, -20, -22, -27
MMP-7, -26
MMP-2, -9
MMP-11, -28
MMP-21
MMP-14, -15, -16, -24
MMP-17, -25
MMP-23
Table 1. Domain structural classification of MMPs
1) Basic/Common organization: signal peptide, prodomain, catalytic domain with Zn2+ active site, hinge region and  
carboxy-terminal hemopexin-like module, SH = thiol group in the prodomain bound to Zn ion in the inactive state of 
MMP; 2) No hemopexin domain; 3) Gelatin-binding, Fibronectin repeat (Fn); 4) Furin-activated, Furin cleavage site 
(Fr); 5) Vitronectin-like (Vn) motif in the prodomain; 6) Transmembrane Type I (TM), Cytosolic (C) region; 7) Trans-
membrane Type I with Glycosylphosphatidylinositol (GPI) anchor; 8) Transmembrane Type II with Cysteine array (Cys) 
and Ig-like domain.
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in proMMP activation. MMP-11, on the other 
hand, has very weak activity toward ECM mol-
ecules, but cleaves serpins more readily. MMP-
11 has a furin recognition motif RX[R/K]R 
at the C-terminal end of the propeptide and 
therefore it is activated intracellularly. 
 ❖ Matrilysins (MMP-7 and MMP-26) lack a he-
mopexin domain. MMP-7 is synthesized by ep-
ithelial cells and is secreted apically. Besides 
ECM components it processes cell surface mol-
ecules such as pro-α-defensin, Fas-ligand, pro-
tumor necrosis factor α, and E-cadherin. MMP-
26 is expressed in normal cells such as those of 
the endometrium and in some carcinomas. It 
digests several ECM molecules, and unlike most 
other MMPs, it is largely stored intracellularly. 
 ❖ MT-MMPs in mammals includes four type I 
transmembrane proteins (MMP-14, MMP-
15, MMP-16, and MMP-24) and two glyco-
sylphosphatidylinositol-anchored proteins 
(MMP-17 and MMP-25). They all have a furin 
recognition sequence RX[R/K]R at the C-ter-
minus of the propeptide. They are therefore ac-
tivated intracellularly and active enzymes are 
likely to be expressed on the cell surface. All 
MT-MMPs except MT4-MMP (MMP-17) can 
activate proMMP-2. MT1-MMP (MMP-14) 
has collagenolytic activity on collagens I, II, 
and III.
 ❖ Other MMPs include seven MMPs (MMP-12, 
MMP-19, MMP-20, MMP-21, MMP-23, MMP-
27, the human orthologue of chick embryo 
MMP-22, and MMP-28) that are not grouped 
in the above categories although MMP-12, 
MMP-20 and MMP-27 have similar structures 
and chromosome location as stromelysins. Me-
talloelastase (MMP-12) is expressed primari-
ly in macrophages, but is also found in hyper-
trophic chondrocytes and osteoclasts. It di-
gests elastin and a number of ECM molecules. 
It is essential in macrophage migration. MMP-
19 digests many ECM molecules including the 
components of basement membranes. It is also 
called RASI (rheumatoid arthritis synovial in-
flammation) as it is found in the activated lym-
phocytes and plasma from patients with rheu-
matoid arthritis. It is recognised as an autoan-
tigen in patients with rheumatoid arthritis and 
systemic lupus erythematosis. It is also widely 
expressed in many organs including proliferat-
ing keratinocytes in healing wounds. Ename-
lysin (MMP-20) is expressed in newly formed 
tooth enamel and digests amelogenin. MMP-
21 was originally found in Xenopus and more 
recently in mice and humans. It is expressed 
in various fetal and adult tissues and in basal 
and squamous cell carcinomas. It digests gela-
tin, but information about the action on ECM 
components is not known. MMP-23 is a unique 
member as it has unique C-terminal cysteine-
rich immunoglobulin-like domains instead of 
a hemopexin domain. The propeptide lacks a 
cysteine switch. It is proposed to be a type II 
membrane protein having a transmembrane 
domain at the N-terminal of the propeptide, 
but the enzyme is released from the cell as the 
membrane anchored propeptide is cleaved by a 
proprotein convertase. MMP-27 was first found 
in chicken embryo fibroblasts. Chicken MMP-
27 digests gelatin, casein and causes autolysis of 
the enzyme. Little information is available on 
the activity of the mammalian enzyme. Epily-
sin (MMP-28) is expressed in many tissues such 
as lung, placenta, heart, gastrointestinal tract 
and testis. The enzyme expressed in basal ke-
ratinocytes in skin is considered to function in 
wound repair. MMP-21, MMP-23 and MMP-
28 have a furin recognition sequence before the 
catalytic domain and therefore they are likely to 
be activated intracellularly and secreted as ac-
tive enzymes.
2.3. Classification of MMP family members
The MMPs are zinc proteases which belong to 
metalloprotease family and are responsible for deg-
radation of extracellular matrix proteins, activating 
proMMPs, processing various receptors and bioac-
tive molecules (Table 2) (16). For a more complete list 
of MMP substrates see Nagasse et al. (15) and Yong 
et al. (17).
2.4. Regulation of metalloproteinase activity
The activity of metalloproteinases is tightly reg-
ulated, as these molecules are potent proteolytic en-
zymes that can cause widespread destruction. As 
for all secreted proteinases, the catalytic activity of 
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MMPs is regulated at the following points: gene ex-
pression, compartmentalization, i.e., pericellular ac-
cumulation of enzyme, proenzyme (or zymogen) ac-
tivation, and enzyme inactivation, as well as it is fur-
ther controlled by substrate availability and affinity 
(20,21).
 ❖ A first level of regulation is at their transcrip-
tion, as most MMPs are not constitutively ex-
pressed but are transcribed after cell activation. 
Transcription of many MMPs is promoted by 
inflammatory cytokines, growth factors, che-
mokines, oncogenes and cell-cell or cell-matrix 
interactions (17). 
 ❖ A second level of regulation is the post-trans-
lational modifications of MMPs. Many MMPs 
are expressed as inactive zymogens in which the 
cysteine residue at the propeptide region binds 
the zinc ion present at the catalytic site. Acti-
vating factors include the plasminogen-plas-
min cascade, as well as other MMPs that dis-
rupt the interaction between cysteine and zinc 
(the so-called “cysteine switch” mechanism) 
and then remove the propeptide region for 
full activation of the enzyme. Non-proteolytic 
compounds such as sulphydryl-reactive agents 
(4-aminophenylmercuric acetate) and denatur-
ants (urea) can also activate zymogens. A sub-
set of MMPs contains a cleavage site for furin-
like prohormone convertases between the pro-
peptide and catalytic domains; this subset in-
cludes the MT-MMPs, which are activated dur-
Member Common name Collagen type, proMMPs and other matrix substrates
MMP-1
MMP-2
MMP-3
MMP-7
MMP-8
MMP-9
MMP-10
MMP-11
MMP-12
MMP-13 
MMP-14 
MMP-15 
MMP-16 
MMP-17 
MMP-18
MMP-19
MMP-20
MMP-21
MMP-22
MMP-23
MMP-24
MMP-25
MMP-26
MMP-27
MMP-28
Collagenase 1
Gelatinase A
Stromelysin 1
Matrilysin
Collagenase 2
Gelatinase B
Stromelysin 2
Stromelysin 3
Metalloelastase
Collagenase 3
MT1-MMP
MT2-MMP
MT3-MMP
MT4-MMP
Collagenase 4
RASI 1
Enamelysin
Xenopus MMP
Chick embryo MMP
Cysteine array MMP
MT5-MMP
MT6-MMP
Matrilysin 2/endometase
Human MMP-22
Epylisin
I, II, III, VII, VIII, X, proMMP-2/-9, Agg, Gel, PG
I, III, IV, V, VII, X, XI, XIV, proMMP-1/-9/-13, Agg, EL, FN, 
Gel, LN, PG, VN
III, IV, IX, X, XI, proMMP-1/-7/-8/-9/-13, Agg, EL, FN, Gel, 
LN, PG, VN
IV, X, proMMP-1/-2/-9, Agg, Cas, EL, FN, Gel, LN, PG, VN
I, II, III, V, VII, VIII, X, Agg, EL, FN, Gel, LN
IV, V, VII, X, XIV, Agg, EL, FN, Gel, PG, VN
III, IV, V, IX, X, proMMP-1/-8, Agg, EL, FN, Gel, LN, PG
IV, EL, FN, Gel, LN
IV, Cas, EL, FN, Gel, LN, PG, VN
I, II, III, IV, VII, IX, X, XIV, proMMP-9, Agg, FN, Gel
I, II, III, proMMP-2/-13, Agg, EL, FN, Gel, LN,
proMMP-2, Agg, FN, Gel, LN
III, proMMP-2, Gel, FN
Fibrinogen/fibrin
I
IV, Gel, FN, LN
Amelogenin
Gel
Cas, Gel
Gel
proMMP-2, Gel
IV, Gel, FN
IV, Gel, FN
Gel, Cas
Cas
Table 2. Matrix metalloproteinase family members, name and main substrates
MMP-4, MMP-5 and MMP-6 were found to be identical to other MMPs. Therefore, these are not listed according to this 
nomenclature. MMP-27 is the human orthologue of chick embryo MMP-22. Agg, aggrecan; Gel, gelatin; PG, ptoteogly-
can link protein; EL, elastin; FN, fibronectin; LN, laminin; VN, vitronectin; Cas, Casein; MT, membrane type; RASI 1, 
rheumatoid arthritis synovial inflammation 1.
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ing secretion and appear on the cell surface in 
the active form. 
 ❖ A third level of regulation of MMP activity 
is by the interaction of active MMPs with tis-
sue inhibitors of metalloproteinases (TIMPs). 
Four TIMPs are now known and they cause 
inactivation by binding to the catalytic site of 
MMPs. Interestingly, TIMPs are also required 
for the activation of some MMPs. In this re-
gard, a complex formed by TIMP-2 and the car-
boxyl terminus of proMMP-2 has been found 
to bind MT1-MMP (MMP-14) on the cell sur-
face. An adjacent MT1-MMP molecule then re-
moves the propeptide region of MMP-2. The 
proMMP/TIMP/MT-MMP trimolecular com-
plex highlights another feature of MMP regula-
tion: the active proteinase is found focally in the 
pericellular region, rather than being diffusely 
distributed. 
In addition, other means also exist to localize 
MMP activity to the pericellular region. For exam-
ple, activated MMP-2 can bind the αvβ3 integrin, 
whereas active MMP-9 can interact with the hyal-
uran receptor CD44 on the cell membrane.
3. BIOLOGICAL EFFECTS OF MMPS 
IN NERVOUS SYSTEM ONTOGENY
MMPs are expressed in the central nervous sys-
tem (CNS) during development, pointing out to their 
possible importance in brain maturation. Expression 
levels of MMP-2, MMP-9, and TIMP-1 were stron-
gest in the mouse neocortex during the embryonic 
stages supporting a role for these factors in the con-
trol of neuronal proliferation and migration. Their 
activity during early postnatal life suggests addition-
al roles in events involved in neuronal survival and 
differentiation, as well as gliogenesis, including mi-
gration of astrocytes and oligodendrocyte precursors 
(22).
Furthermore, MMPs are rapidly upregulated 
after nearly all types of injury to the CNS indicat-
ing their possible beneficial effects in tissue repair. 
Although metzincins and TIMPs have been mostly 
studied in the context of nervous system disease and 
injury, the last decade has witnessed a growing in-
terest of neuroscientists for their role in developmen-
tal plasticity and repair. The molecular and cellular 
events that support post-lesion repair of the mature 
CNS recapitulate some of the processes set in motion 
during development. Strong evidence now indicates 
that the metzincin/TIMP system plays critical roles 
in these phenomena (23). 
3.1. Metalloproteinases and embryonic 
neurogenesis
The mechanisms by which metalloproteinas-
es regulate neurogenesis have not yet been fully de-
fined. In concordance with the classic role of MMPs 
in modulating the motility of cells across tissue ma-
trices, metalloproteinases might regulate the migra-
tion of precursor cells to their destinations during 
neural development. Neural stem cells express MMP-
2 and all four TIMPs, and the migration of an oligo-
dendrocyte progenitor requires MMP activity in vi-
tro. There is experimental evidence for the stimulat-
ing role of some MMPs as key molecular effectors on 
the proliferation and migration of embryonic neural 
stem/progenitor cells (Fig. 2) (24). One possibility is 
the modulation of the ECM and/or other guidance 
molecules. Many of the molecules that effect cell fate 
decisions in neurogenesis are substrates for metallo-
proteinases. There is substantial evidence that metal-
loproteinases regulate also the axonal growth. The 
metalloproteinase activity is localized to the growth 
cones of neurons, and inhibition of metalloprotein-
ase activity reduces growth cone motility. In PC12 
cells (a cell line derived from a pheochromocytoma 
of the rat adrenal medulla, that has an embryonic or-
igin from the neural crest and contains a mixture of 
neuroblastic cells and eosinophilic cells) treated with 
nerve growth factor (NGF), neurite extension corre-
lates with the localization of MMP-3 by immunohis-
tochemistry to the growth cones. Active proteolyt-
ic activity demonstrated by in situ zymography with 
gelatin-FITC (fluorescein isothiocyanate) as a sub-
strate has also been shown in cerebellar neurons and 
at the edge of growth cones from dorsal root gangli-
on neurons (17). MMP-9 controls survival of neu-
rons by regulating laminin-integrin β1 signaling 
during developmental neuronal death in the new-
born rat hippocampus (25). MT5-MMP expression 
is closely associated with the formation of dendritic 
trees of Purkinje neurons. Growth factors and ECM 
molecules that promote neurite outgrowth, such as 
NGF and laminin, increase the expression of MMP-
2 in neurons. So, the formation of neurites and the 
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activity of growth cones during development are as-
sociated with the expression of several metallopro-
teinases. This relationship is functionally coupled, as 
the reduction of metalloproteinase activity decreases 
neurite outgrowth and affects guidance decisions. It 
is known that several MMPs have important role in 
the histogenesis of the developing cerebellum. Dur-
ing the early postnatal period between PD3-PD12, 
the immunoreactivity of MMP-2 and MMP-9 was 
increased in both the external and internal granule 
layers of the cerebellar cortex. MMP-2 was mainly lo-
calized in the Bergmann glial fibers and the Purkin-
je cell layer, whereas MMP-9 was detected intensively 
in the Purkinje cell layer and the extracellular space 
of the molecular layer. These findings showed that 
MMP-2 and MMP-9 are involved in diverse neuro-
nal functions including migration, process exten-
sion, and synaptic plasticity during the postnatal cer-
ebellar morphogenesis (26).
The MMP/TIMP system has been shown to 
influence neural cell differentiation and survival. 
TIMP-2 acts in synergy with NGF to induce cell cy-
cle arrest of neuronal precursors and promote neu-
ronal differentiation, while MMP-9 and MMP-12 
regulate oligodendrocyte maturation and myelina-
tion possibly through the modulation of insulin-like 
growth factor bioavailability (27). In vivo, postnatal 
programmed cell death of cerebellar granule cell pre-
cursors is reduced in MMP-9 KO mice (28). These 
data underscore the importance of MMPs in the con-
trol of neuronal survival.
Cell migration is another pivotal developmental 
function that involves metalloproteinase activities. 
Migration of cerebellar granule cell precursors cor-
relates with changes in MMP-9 expression and ex-
ternal granular layer migration is delayed in MMP-
9 KO mice or after blockade of MMP-9 activity with 
neutralizing antibodies in cerebellar explants (28). 
Another gelatinase, MMP-2, regulates the motility 
of cultured non-stimulated astrocytes possibly via an 
interaction with β1 integrins and the actin cytoskel-
eton (29). The migration of individual neuroblasts 
along the RMS (rostral migratory stream) from the 
SVZ (subventricular zone) to the olfactory bulb or 
those migrating radially within the olfactory bulb is 
perturbed after birth by furin inhibitors thought to 
inhibit the activation of MT-MMPs.
Perhaps the most critical role of metzincins in 
developmental plasticity is regulation of neurite out-
growth. Metalloproteinase activity is permissive for 
axonal extension via cleavage of inhibitory ECM pro-
teins, e.g. chondroitin sulfate proteoglycans (CSPGs). 
MMPs also mobilize ECM-sequestered trophic fac-
tors such as epidermal growth factor (EGF). In addi-
tion, MMP-7 can proteolytically convert the pro-
forms of brain-derived neurotrophic factor (BDNF) and 
NGF into the biological active forms and MMP-9 de-
grades active NGF (30). In turn, NGF and BDNF can 
stimulate the expression and activity of MMP-2, -9, 
and -14 (23). This proteolysis can either activate or 
inhibit signaling pathways. Altogether, these data re-
inforce the idea that matrixins and TIMPs may work 
in concert to regulate neurite extension/pathfinding 
during development.
3.2. Other MMP functions in the developing 
nervous system
A beneficial role for metalloproteinases in ax-
onal guidance, myelinogenesis and synaptogenesis 
during development seems to be supported by sev-
eral lines of evidence (Fig. 2). MMPs are implicat-
ed in the guidance of vertebrate retinal ganglion cell 
axons and different metalloproteinases function to 
regulate axon behaviour at distinct choice points: an 
MMP is important in guidance at the optic chiasm 
and the target, while either a different MMP is re-
quired for axons to make the turn in the mid-dien-
cephalon (31). Another role for MMPs in CNS de-
velopment might lie in myelinogenesis, the process 
whereby oligodendrocytes extend several process-
es from their soma that reach and enwrap axons to 
form myelin. The initial expansion of oligodendrog-
lial processes is immense and could require remod-
elling of the brain matrix by MMPs. This hypothe-
sis has been tested and oligodendrocytes were found 
to express MMP-9 during the period of myelinogen-
esis. Furthermore, the inhibition of MMP activity 
in vitro prevented the extension of oligodendroglial 
processes (17). In parallel with myelinogenesis, me-
talloproteinases also participate in axon elongation. 
Early studies noted the presence of proteolytic activ-
ity at neuronal growth cones during attachment and 
reattachment events. Some of the activity is proba-
bly contributed by metalloproteinases, as interfer-
ence with MMP activity inhibited growth-cone mo-
16  Scripta Scientifica Medica, vol. 47, No 1, 2015, 9-22
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tility. Inducers of neuronal differentiation and ax-
onal outgrowth, such as NGF, laminin or retinoic 
acid, enhanced the expression of MMP-2, MMP-3 
and MMP-9 by dorsal root ganglion neurons (17). 
Although these data implicate metalloproteinases in 
the creation of penetrable paths for axonal elonga-
tion, metalloproteinases can also regulate guidance 
cues for growth cones. Ephrins are guidance mol-
ecules that bind to receptor tyrosine kinases of the 
Eph family. When the growth cone of a neuron that 
expresses Eph receptors encounters ephrin ligands 
on the surface of another cell, this facilitates the ad-
herence of the cells to each other and bidirection-
al signalling to occur. The growth cone then over-
comes these adhesive forces and breaks away from 
the ephrin surface. MMPs and TIMPs may work 
in concert to regulate neurite extension/pathfind-
ing during development. During brain maturation 
NMDA receptors promotes dendritic spine develop-
ment and remodelling through MMP-mediated in-
tercellular adhesion molecule-5 (ICAM-5) cleavage 
(32).
Among known MMP substrates are several 
proteins that play important roles in synaptogenesis, 
synaptic plasticity, and long-term potentiation (LTP). 
MMP-directed cleavage of these proteins can im-
pact the formation and function of synapses within 
the brain. Pyramidal neurons in the hippocampus, 
and other large neurons, are surrounded by perineu-
ronal nets that are composed of brevican, tenascin-
R, and laminin, each of which is subject to proteo-
lytic cleavage by MMPs. Tenascin-R knockout mice 
show deficits in learning and memory and LTP, as do 
at least two MMP knockouts. Impaired LTP is also 
seen in BDNF knockout mice, which is interesting in 
that pro-BDNF can be processed into mature BDNF 
by several MMPs and thereby regulate activation of 
the high-affinity BDNF receptor TrkB. At the synap-
tic level, MMP substrates also include ephrins, Eph 
receptors, and cadherins, which are also involved in 
synapse development and plasticity (33).
MMP-2 has been suggested to be largely in-
volved in the development of human brain microves-
sels. Endothelial cells and pericytes tightly interplay 
in both angiogenesis mechanisms, by ECM proteoly-
sis, and angiogenesis regulation, by local (autocrine/
juxtacrine) vascular endothelial growth factor (VEGF) 
action (34).
Fig. 2. Functional involvement of MMPS in the developing and adult nervous system  
MMPs regulate developmental and repair processes such as the genesis of progentors from a neural stem cell, migration 
and differentiation of the progenitors into neurons and oligodendrocytes. They participate also in the subsequent forma-
tion of axons, synapses and myelin. The factors and mechanisms by which MMPs control these processes are indicated. 
Similarly, following an injury, metalloproteinases are involved in the regenerative events through specific mechanisms. 
ECM, extracellular matrix; EGFR, epidermal growth factor receptor; LTP, long-term potentiation; Nogo, neurite out-
growth inhibitor
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4. ROLE OF MMPS IN THE ADULT 
NERVOUS SYSTEM
4.1. Plasticity within the normal adult brain
MMPs/TIMPs play a significant role in LTP 
and learning. Several reports support a role for 
MMPs in physiological LTP at diverse brain regions. 
The pivotal role for MMP-9 in LTP was first estab-
lished by Nagy et al. (35) who revealed that MMP-
9 protein levels and proteolytic activity were rapidly 
increased by stimuli that induce late-phase LTP. Fur-
thermore, using MMP-9 KO mice, as well as broad-
spectrum MMP inhibitors, the authors reported de-
ficient late-phase LTP in hippocampal slices at the 
CA3 to CA1 pathway. Taken together, these data in-
dicate that MMPs are involved in various aspects of 
LTP, with MMP-9 needed for late-phase LTP and 
MMP-3 for LTP induction (36). In this context, it is 
noteworthy that MMP-3 acts upstream of MMP-9, 
i.e., MMP-3 regulates MMP-9 activation. Given the 
role of MMPs in hippocampal LTP, it comes as no 
surprise that MMP inhibition has also been linked 
to memory deficits in behavioral learning paradigms 
(35,37). Sympathetic neurons secrete MMP-2 and 
MT1-MMP to control nerve sprouting via pro-NGF 
conversion (38).
There is also data that indicates a role for me-
talloproteinases in synaptic plasticity related to 
the learning and memory (Fig. 2) (39,40). Both the 
MMP-9 transcript and protein are upregulated in 
the cell bodies and dendrites of hippocampal neu-
rons within hours of experimental kainate stimula-
tion, and the protease appears to have a role in the 
dendritic remodelling (41). In traumatic brain inju-
ry involving the hippocampus, the resultant reactive 
synaptic plasticity corresponds to increased MMP-3 
expression (42).
In addition to developmental plasticity dis-
cussed above, there are multiple physiological and 
pathological phenomena relying on plasticity within 
the adult brain, including learning and memory, epi-
leptogenesis, and drug addiction. Several experimen-
tal paradigms, mimicking some aspects of plastici-
ty, have also been identified, with LTP and long-term 
depression (LTD) being the most prominent. Myriad 
molecules have been proposed to play a role in brain 
plasticity. Most studies focus on external informa-
tion conveyed to neurons predominantly by means 
of neurotransmitters, neurotrophins, cytokines and 
steroids. However, much less is known about a major 
extracellular molecular brain structure surrounding 
neuronal synapses, i.e., ECM and cell adhesion mol-
ecules. Since plasticity is associated with post-synap-
tic structural alterations, proteolytic ECM modifica-
tions likely contribute to plasticity.
4.2. Plasticity in the post-injured adult brain
In the injured adult CNS, the metalloproteinas-
es have mainly detrimental activities but some bene-
ficial functions are also possible (Fig. 2) (Table 3) (43, 
44). What could they be? It is possible that metallo-
proteinases enable the migration of precursor cells to 
injured sites to replenish lost cells (45). Accumulat-
ing data now indicate that MMPs may play beneficial 
roles by mediating the neurogenic response in the 
subventricular zone after brain injury such as trau-
ma, ischemia, and hemorrhage. By allowing neuro-
blasts to expand and migrate, MMPs should facili-
tate the endogenous recovery response in a damaged 
brain (46,47). 
A role in facilitating axonal regrowth, remye-
lination and angiogenesis is also possible on the ba-
sis of the functions of these proteases in development 
(48). Another possible role of MMPs in the adult CNS 
might involve their potential to affect signal trans-
duction by, for example, linking G-protein-coupled-
receptor signalling with the EGF pathway. In this 
context, the engagement of G-protein-coupled re-
ceptors has been shown to activate a membrane-as-
sociated metalloproteinase that converts proheparin-
binding EGF to its mature form, triggering EGF sig-
naling (17). Regulation of synaptic plasticity could be 
another function of metalloproteinases in CNS inju-
ry (49). MMPs could also participate in terminating 
inflammation in the CNS, in contrast to the perpetu-
ation of inflammation. The prolonged incubation of 
IL-1β with MMP-3, and to a lesser extent MMP-2 and 
-9, resulted in IL-1β degradation injury (50). Further-
more, MMP-2 binds to the chemokine macrophage 
chemoattractant protein 3 (MCP-3) and cleaves its 
first four amino-terminal amino acids. The cleaved 
MCP3 binds to several chemokine receptors, acting 
as an antagonist. So, MMPs expressed in the CNS 
might serve to abolish a chemotactic gradient for leu-
kocyte entry. Interestingly, MMP-9 has been report-
ed to truncate the amino terminus of IL-8, leading 
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to a 30-fold potentiation of IL-8 activity. Conversely, 
MMP-9 degraded chemokines, such as gro-α, leav-
ing RANTES (also known as SCYA5) and MCP-2 in-
tact (17).
Matrix metalloproteinases have been suggested 
as key facilitators of successful axonal regeneration 
for several reasons. First, MMPs add to the clear-
ance of cellular and matrix debris at the site of inju-
ry. Second, all major constituents of the glial scar are 
substrates of at least one MMP (51,52) and increased 
MMP activity reduces glial scarring and associated 
inhibitory molecules. In particular, the CSPGs have 
been denoted for their strong inhibitory impact on 
axonal regeneration (53) and are subject to cleavage 
by MMPs. Indeed, the repulsion of neurite growth 
cones and “masking” of neurite-promoting laminin 
by CSPGs, can be (partially) abrogated by MMP (52). 
Third, MMPs are also able to degrade myelin-derived 
inhibitory ligands released by degenerating CNS ax-
ons, such as neurite outgrowth inhibitor (Nogo), my-
elin-associated glycoprotein, oligodendrocyte my-
elin glycoprotein (OMgp), and myelin basic protein 
(MBP) (42,52,53). Fourth, besides disarming inhibi-
tory ECM and signaling molecules, MMPs can also 
unmask, activate, or release others that have a ben-
eficial effect on CNS repair. As such, they can indi-
rectly provide neurotrophic support to regenerating 
axons via the release of sequestered growth factors 
(e.g., release of basic fibroblast growth factor (bFGF) 
from ECM heparin sulphate proteoglycans) or the 
conversion of inactive progrowth factors to their ac-
tive forms, e.g., NGF and BDNF (42, 52, 54). Final-
ly, as the directed outgrowth of axons requires ex-
tensive motility and infiltration within the nervous 
tissue, MMPs can invoke: “focalized” proteolysis 
at the growth cone, thereby reorganizing the ECM 
to facilitate attachment and motility of the growing 
axon (55). Experimental evidence demonstrates that 
MMP-2 promote adult axon regeneration by olfacto-
ry ensheathing cells (56).
Although thus far only described in the brain 
and spinal cord, it can be assumed that these MMP 
actions can be extrapolated to the entire CNS, in-
cluding the retina and optic nerve. Indeed, stimula-
tion of axonal regeneration after optic nerve transec-
tion in rats, by intravitreal transplantation of a pe-
ripheral nerve segment, coincides with significant-
ly enhanced MMP activity in the regenerating optic 
nerve as compared with the nonregenerating optic 
nerve (53). More specifically, MMP-2, MMP-9, and 
to a lesser extent also MMP-1 and -3, are upregulated 
in the proximal optic nerve stump and at the site of 
the optic nerve injury, while TIMP-1 and -2 are sup-
pressed. This immediate local upregulation of MMP-
2 and MMP-9 by reactive astrocytes, that is coin-
ciding with post injury inflammation, is thought to 
clear tissue debris, in concert with invading macro-
phages. The later burst in gelatinase activity (i.e., 8 
Beneficial effects Detrimental effects
 ❖ Cell-fate specification
 ❖ Migration of neuronal precursors 
 ❖ Angiogenesis 
 ❖ Survival of cells
 ❖ Axonal growth
 ❖ Myelinogenesis
 ❖ Signaling
 ❖ Learning and memory
 ❖ Terminate inflammation
 ❖ Repair processes
 ❖ Inflammation
 ❖ Disruption of blood-brain barrier
 ❖ Demyelination
 ❖ Neuronal death
 ❖ Oxidative stress
 ❖ Toxicity
 ❖ Stroke
 ❖ Trauma
 ❖ Tumorigenesis 
 ❖ Neurodegenerative diseases
Table 3. Metalloproteinases in the nervous system
MMPs play crucial beneficial roles in CNS development, normal functioning and regeneration but they are detrimen-
tal mediators in CNS inflammation, infection and injury destroying neurons, axons and myelin and resulting in various 
disease conditions.
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days post injury), which colocalizes with ECM com-
pounds of the glial scar, might serve to break down 
and dissolve the glial scar, thereby clearing the path 
for regenerating axons (53). Remarkably, gelatinase 
activity only rarely colocalizes with regenerating op-
tic nerve axons, in contrast to regenerating periph-
eral nerves, where growth cones secrete MMP-2 and 
MMP-3 to facilitate the progression of dorsal root 
ganglia cell axons on the peripheral nerve basal lami-
na (57). Instead, reactive astrocytes at the site of inju-
ry appear to be the major source of gelatinases in the 
CNS (53). Taken together, MMPs can potentially play 
part in many different aspects of successful axonal 
regeneration. In the optic nerve, it is already evident 
that they can add to the conversion of the nerve en-
vironment from a repressive to a facilitative substra-
tum for axon growth. Moreover, endogenous MMP-
2, produced by retinal astrocytes, seems to be essen-
tial to neurite outgrowth in an in vitro mouse retinal 
explant model (58). 
Metzincins also play a role in post-injury plas-
ticity, particularly via the regulation of the glial scar. 
The glial scar effectively confines the lesion, but also 
constitutes a major obstacle for axon regeneration, 
partially due to the accumulation of inhibitory mol-
ecules, e.g., CSPGs, myelin ligands. MMP-9 contrib-
utes to the early deleterious effects of spinal cord in-
jury and to astrocyte motility during glial scar for-
mation (59). Accordingly, MMP-2 KO mice exhibit 
reduced spontaneous axon regeneration and func-
tional recovery with a concomitant increase in CSPG 
levels after moderate spinal cord injury.
A successful regeneration after neuronal injury 
concomitant with axonal degeneration, implies the 
generation of new synapses in order to regain neuro-
nal functionality. As synaptogenesis depends on dy-
namical changes of the ECM and cleavage of pericel-
lular protein-like growth factors and adhesion mole-
cules, a role for MMP-2 in this elaborate process has 
been proposed, but only limited evidence has been 
gathered. Additionally to de novo synaptogenesis of 
newly regenerated axons, reorganization of synap-
tic contacts from neighboring axons also occurs, de-
fined as post-injury synaptic plasticity, a process in 
which MMP-9 has recently been implied. Indeed, 
enhanced synaptic activity and subsequent tissue re-
modelling, triggered by kainate administration, re-
sults in an upregulation of MMP-9 mRNA, protein 
and activity in the adult rat hippocampal dentate gy-
rus at the site of granule cell dendrites, implicating a 
role for MMP-9 in activity-dependent remodelling of 
dendritic architecture with possible effects on synap-
tic physiology (41).
Remyelination is an important process during 
nerve repair and regeneration in the nervous system 
and has been associated with several MMPs (60, 61). 
Since migration and maturation of oligodendrocyte 
precursors and the ensheatment of axons by their 
processes form an essential part of the remyelinat-
ing event and need extensive ECM remodeling, pro-
teases, and MMPs in particular, have been suggested 
as promising candidate molecules herein (42). MMP-
9 facilitates remyelination in part by processing the 
inhibitory neuron-glial antigen 2 proteoglycan (62) 
and activates cell signaling promoting migration of 
Schwann cells after injury (63).
In summary, metalloproteinases in the CNS 
have clear beneficial functions during development 
and might also have positive effects after injury. 
These effects contrast with the better-described det-
rimental roles of metalloproteinases in the CNS. Al-
together, these findings highlight positive roles for 
matrixins in cell-mediated injury repair through 
the mobilization of endogenous neural cell precur-
sors and the remodelling of the lesion environment 
by grafted cells.
5. CONCLUSIONS AND FUTURE 
PERSPECTIVES
Matrixins and their inhibitors are both foes and 
friends in nervous system physiopathology. Howev-
er, many questions on the biology of these enzymes 
remain open and addressing them represents a tre-
mendous challenge for future research. We still have 
very limited knowledge of their in vivo substrates and 
an incomplete understanding of the spatio-temporal 
pattern of expression of most MMPs. Many ques-
tions regarding the mechanisms of metalloprotein-
ase action in health and disease need to be answered. 
What signal transduction pathways are activated 
upon intracellular and extracellular metalloprotein-
ase proteolytic processing? What are the other func-
tions of non-active proteinases and what proteins do 
they interact with at the plasma membrane? Do ma-
trixins elicit activities independent of proteolysis in 
the nervous system? Increasing our basic knowledge 
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on the biology of MMPs should improve the efficacy 
of potential therapeutic strategies for promoting the 
beneficial or inhibiting the detrimental effects of me-
talloproteinase activity in the nervous system.
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